This is the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”. This ebook covers: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers… Read More
In the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”, we discuss: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers for LC-MS… Read More
Listen to this article on the DDW Podcast: Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery. Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors operate over the next five… Read More
US biotechnology start-up LivFul has secured a $1.5m investment to expand its work saving lives from malaria and other insect-borne diseases, and to support the company’s growth plans. The company’s major markets are now opening up following the pandemic, with interest in Livful’s Enhanced Insect Repellent ramping up. Livful is… Read More
The latest DDW eBook reveals the critical role analytical tools and equipment have in helping to advance drug discovery research. It is sponsored by Sartorius. This ebook covers: Opinions on the major trends in lab analytics. Measuring the pharmacokinetics of monoclonal antibodies. … Read More
Scientists from Tel Aviv University have deciphered the mechanism that enables skin cancer to metastasise to the brain and were able to delay the spread of the disease by 60-80% using existing treatments. Once melanoma, or skin cancer, spreads to the brain, it becomes extremely aggressive. Patients… Read More
Learn about the critical role analytical tools and equipment have in helping to advance drug discovery research in this DDW eBook sponsored by Sartorius. This eBook covers: Opinions on the major trends in lab analytics. Measuring the pharmacokinetics of monoclonal antibodies. Best practices in cell line development Access the… Read More
Join DDW for this exclusive free event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific. It will take place on 19 October, 2022, 4PM BST, 8AM PDT. Register free here. The aim of… Read More
Terumo Blood and Cell Technologies (BCT) has launched the Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene therapy (CGT) sector. Responding to the industry’s need for earlier automation to potentially limit additional and… Read More
AstraZeneca’s Tezspire (tezepelumab) has been approved in the European Union as an add-on maintenance treatment in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal product. The approval by the European Commission was based on results… Read More
Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong explores the rise of drug repurposing and the benefits and disadvantages it brings to drug discovery and development. Drug repurposing, the act of finding new clinical targets for both approved and unapproved drugs, has emerged as a viable alternative… Read More
UMC Utrecht and its partners have received a research grant to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects. Close to €800,000 was awarded by Health~Holland to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA)… Read More
Ori Biotech and the Cell Therapy Manufacturing Center (CTMC) have partnered to accelerate process development, clinical implementation, and commercialisation of novel cell therapies. The partnership will combine Ori’s technology platform with CTMC’s manufacturing capabilities and, in the first instance, will focus on a cell therapy invented by Dr Sattva Neelapu,… Read More
Listen to this article on the DDW Podcast: The Fall 2022 issue of the DDW is out now. DDW Editor Reece Armstrong comments. There’s no doubting that when the time came for the life sciences industry to step up during the Covid-19 pandemic, it delivered. From diagnostics to the launch of… Read More
This paid-for advertorial by Synthego appeared in Volume 23 – Issue 4, Fall 2022. Rise of CRISPR-mediated Therapies After more than two decades of successes and failures, the promise of cell and gene therapy to treat the root cause of many human diseases is now starting to redefine modern medicine. Read More
Pfizer has extended its multi-year partnership with CytoReason to use CytoReason’s artificial intelligence (AI) technology for Pfizer’s drug development programs. Pfizer will make a $20 million equity investment, have options to license CytoReason’s platform and disease models, and fund supplementary project support. This deal which has the potential to be worth up… Read More
